IP Library › Granted Patent US 12,717,624
Granted Patent B2
US 12,717,624 · App. 17/088,387 · Granted Aug 25, 2026

Integrated value chain risk-based profiling and optimization

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,717,624
App. No.
17/088,387
Filed
Nov 3, 2020
Granted
Aug 25, 2026
Kind
B2
Art Unit
2153
USPC
718/104
Assignments (5)
CHANGE OF ADDRESS Recorded Oct 1, 2024
From: QOMPLX LLC
To: QOMPLX LLC
Reel/Frame 069083/0279 →
CHANGE OF NAME Recorded Sep 27, 2023
From: QPX LLC
To: QOMPLX LLC
Reel/Frame 065036/0449 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY PREVIOUSLY RECORDED AT REEL: 064674 FRAME: 0408. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 20, 2023
From: QOMPLX, INC.
To: QPX LLC
Reel/Frame 064966/0863 →
PATENT ASSIGNMENT AGREEMENT TO ASSET PURCHASE AGREEMENT Recorded Aug 23, 2023
From: QOMPLX, INC.
To: QPX, LLC.
Reel/Frame 064674/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2020
From: SELLERS, ANDREW; CRABTREE, JASON
To: QOMPLX, INC.
Reel/Frame 054426/0467 →
Continuity (86)
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16864133 · Apr 30, 2020
Continuation In Part 15847443 · Dec 19, 2017
Continuation In Part 15790457 · Oct 23, 2017
Continuation In Part 15790327 · Oct 23, 2017
Continuation In Part 15616427 · Jun 7, 2017
Continuation In Part 15141752 · Apr 28, 2016
Continuation In Part 15091563 · Apr 5, 2016
Continuation In Part 14986536 · Dec 31, 2015
Continuation In Part 14925974 · Oct 28, 2015
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16864133 · Apr 30, 2020
Continuation In Part 15847443 · Dec 19, 2017
Continuation In Part 15616427 · Jun 7, 2017
Continuation In Part 14925974 · Oct 28, 2015
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16864133 · Apr 30, 2020
Continuation In Part 15847443 · Dec 19, 2017
Continuation In Part 15489716 · Apr 17, 2017
Continuation In Part 15409510 · Jan 18, 2017
Continuation In Part 15379899 · Dec 15, 2016
Continuation In Part 15376657 · Dec 13, 2016
Continuation In Part 15237625 · Aug 15, 2016
Continuation In Part 15206195 · Jul 8, 2016
Continuation In Part 15186453 · Jun 18, 2016
Continuation In Part 15166158 · May 26, 2016
Continuation In Part 15141752 · Apr 28, 2016
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16915176 · Jun 29, 2020
Continuation In Part 15847443 · Dec 19, 2017
Continuation In Part 15891329 · Feb 7, 2018
Continuation In Part 15860980 · Jan 3, 2018
Continuation In Part 15850037 · Dec 21, 2017
Continuation In Part 15489716 · Apr 17, 2017
Continuation In Part 15673368 · Aug 9, 2017
Continuation In Part 15376657 · Dec 13, 2016
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16915176 · Jun 29, 2020
Continuation In Part 15891329 · Feb 7, 2018
Continuation In Part 15860980 · Jan 3, 2018
Continuation In Part 15788002 · Oct 19, 2017
Continuation In Part 15787601 · Oct 18, 2017
Continuation In Part 15616427 · Jun 7, 2017
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 16915176 · Jun 29, 2020
Continuation In Part 15905041 · Feb 26, 2018
Continuation In Part 15237625 · Aug 15, 2016
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 16777270 · Jan 30, 2020
Continuation In Part 16720383 · Dec 19, 2019
Continuation In Part 15823363 · Nov 27, 2017
Continuation In Part 15725274 · Oct 4, 2017
Continuation In Part 15655113 · Jul 20, 2017
Continuation In Part 15616427 · Jun 7, 2017
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 15683765 · Aug 22, 2017
Continuation In Part 15409510 · Jan 18, 2017
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 16718906 · Dec 18, 2019
Continuation 15879182 · Jan 24, 2018
Continuation In Part 15850037 · Dec 21, 2017
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 15905041 · Feb 26, 2018
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 16191054 · Nov 14, 2018
Continuation In Part 15655113 · Jul 20, 2017
Continuation In Part 15237625 · Aug 15, 2016
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 16654309 · Oct 16, 2019
Continuation In Part 15847443 · Dec 19, 2017
Continuation In Part 16945698 · Jul 31, 2020
Continuation In Part 15931534 · May 13, 2020
Continuation In Part 16660727 · Oct 22, 2019
Continuation In Part 15229476 · Aug 5, 2016
Continuation In Part 15206195 · Jul 8, 2016
Provisional Application 62568298 · Oct 4, 2017
Provisional Application 62568291 · Oct 4, 2017
Provisional Application 62568305 · Oct 4, 2017
Provisional Application 62568312 · Oct 4, 2017
Related Publication 20210173711A1 · Jun 10, 2021
References Cited (33)
US 6256544B1 · Weissinger · 2001 [cited by applicant]
US 7249007B1 · Dutton · 2007 [cited by examiner]
US 8132260B1 · Mayer et al. · 2012 [cited by applicant]
US 8429179B1 · Mirhaji · 2013 [cited by examiner]
US 20030041041A1 · Cristianini · 2003 [cited by examiner]
US 20070012161A1 · Lyles · 2007 [cited by applicant]
US 20080172353A1 · Lim et al. · 2008 [cited by applicant]
US 20090043637A1 · Eder · 2009 [cited by examiner]
US 20090164387A1 · Armstrong · 2009 [cited by examiner]
US 20100228693A1 · Dawson et al. · 2010 [cited by applicant]
US 20110153368A1 · Pierre · 2011 [cited by examiner]
US 20110185432A1 · Sandoval et al. · 2011 [cited by applicant]
US 20120046992A1 · Hu · 2012 [cited by examiner]
US 20120203708A1 · Psota · 2012 [cited by examiner]
US 20130041921A1 · Cooper et al. · 2013 [cited by applicant]
US 20130074143A1 · Bu · 2013 [cited by examiner]
US 20130091539A1 · Khurana · 2013 [cited by examiner]
US 20130347116A1 · Flores et al. · 2013 [cited by applicant]
US 20140040975A1 · Raleigh et al. · 2014 [cited by applicant]
US 20140074826A1 · Cooper et al. · 2014 [cited by applicant]
US 20140245443A1 · Chakraborty · 2014 [cited by examiner]
US 20150073929A1 · Psota · 2015 [cited by examiner]
US 20150095303A1 · Sonmez · 2015 [cited by examiner]
US 20150379445A1 · Wang · 2015 [cited by examiner]
US 20160071035A1 · Chee · 2016 [cited by examiner]
US 20160125751A1 · Barker · 2016 [cited by examiner]
US 20160203234A1 · Piccand · 2016 [cited by examiner]
US 20160275123A1 · Lin et al. · 2016 [cited by applicant]
US 20170011037A1 · Qian · 2017 [cited by examiner]
CN 102253933A · 2011 [cited by applicant]
WO 2011011942A1 · 2011 [cited by applicant]
WO 2014159150A1 · 2014 [cited by applicant]
WO 2017075543A1 · 2017 [cited by applicant]